Guidance on registration - ECHA - Europa
Guidance on registration - ECHA - Europa
Guidance on registration - ECHA - Europa
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>Guidance</str<strong>on</strong>g> <strong>on</strong> registrati<strong>on</strong><br />
Versi<strong>on</strong> 2.0 May 2012 61<br />
Where there were several previous registrants and a joint submissi<strong>on</strong> exists, the potential<br />
registrant will need to c<strong>on</strong>tact the lead registrant to join the joint submissi<strong>on</strong>. Where the same<br />
substance has previously been registered by <strong>on</strong>ly <strong>on</strong>e other company, the potential registrant<br />
will need to make c<strong>on</strong>tact with this previous registrant. They must agree <strong>on</strong> who will be the<br />
lead registrant. In most cases, it would be most sensible if the previous registrant takes over<br />
the role of the lead registrant, as he has already submitted a full dataset. However, the<br />
previous registrant and the potential registrant are also free to agree that the potential<br />
registrant will be the lead registrant and make the joint submissi<strong>on</strong>. In that case, the potential<br />
registrant must create and submit a joint submissi<strong>on</strong> with the full dataset required for the<br />
highest t<strong>on</strong>nage range of the two registrants, and the previous registrant will subsequently<br />
need to join this submissi<strong>on</strong>.<br />
In case the lead registrant ceases manufacture the other registrants will have to c<strong>on</strong>sider the<br />
need to appoint a new lead registrant.<br />
The registrati<strong>on</strong> fees, set by Commissi<strong>on</strong> Regulati<strong>on</strong> (EC) No 340/2008 of 16 April 2008, take<br />
into account whether the submissi<strong>on</strong> is joint or separate.<br />
Legal references: Article 11, Article 19<br />
3.3.2 Opt-out possibilities<br />
A manufacturer or importer may submit certain informati<strong>on</strong> of the registrati<strong>on</strong> dossier<br />
separately (opt-out) in cases where at least <strong>on</strong>e of the following reas<strong>on</strong>s (listed in Article 11(3)<br />
or for substances in intermediates respectively in Article 19(2)) applies:<br />
(a) it would be disproporti<strong>on</strong>ately costly for him to submit this informati<strong>on</strong> jointly; or<br />
(b) submitting the informati<strong>on</strong> jointly would lead to disclosure of informati<strong>on</strong> which he<br />
c<strong>on</strong>siders to be commercially sensitive and is likely to cause him substantial commercial<br />
detriment; or<br />
(c) he disagrees with the lead registrant <strong>on</strong> the selecti<strong>on</strong> of the informati<strong>on</strong> submitted in<br />
the lead registrati<strong>on</strong>.<br />
In this case the registrant has to submit al<strong>on</strong>g with his dossier an explanati<strong>on</strong> as to why the<br />
costs would be disproporti<strong>on</strong>ate, why disclosure of informati<strong>on</strong> would be likely to lead to<br />
substantial commercial detriment or the nature of the disagreement, as the case may be.<br />
Opting out can be partial and refer for example <strong>on</strong>ly to a specific study. More detailed guidance<br />
<strong>on</strong> the opting out possibilities and mechanisms can be found in the <str<strong>on</strong>g>Guidance</str<strong>on</strong>g> <strong>on</strong> data sharing.<br />
Note that even when the registrant decides to exercise his opt-out opti<strong>on</strong>, he<br />
remains a member of the joint submissi<strong>on</strong> and will be able to submit his dossier <strong>on</strong>ly<br />
after the lead dossier has been accepted for processing. Hence, a registrant can opt-out<br />
from certain informati<strong>on</strong> requirements but not from the joint submissi<strong>on</strong> as such.<br />
Legal references: Article 11 (3), Article 19 (2)<br />
3.4 Access to informati<strong>on</strong> and c<strong>on</strong>fidential data<br />
Although the REACH Regulati<strong>on</strong> requires informati<strong>on</strong> to be provided to <strong>ECHA</strong> and potentially<br />
exchanged with the other manufacturers and importers, some provisi<strong>on</strong>s (Articles 118 and<br />
119) to protect commercially sensitive informati<strong>on</strong> are foreseen.<br />
The general provisi<strong>on</strong>s <strong>on</strong> access to informati<strong>on</strong> are as follow:<br />
<br />
Informati<strong>on</strong> that is listed in Article 119 (1) and submitted in the registrati<strong>on</strong> dossier will<br />
be made publicly available <strong>on</strong> the <strong>ECHA</strong> website.<br />
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu